XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 29, 2024
Jul. 01, 2023
Jun. 29, 2024
Jul. 01, 2023
Total revenue $ 1,026,117 $ 1,059,937 $ 2,037,677 $ 2,089,310
Costs and expenses:        
Cost of revenue (excluding amortization of intangible assets) 672,404 660,960 1,339,121 1,312,679
Selling, general and administrative 169,791 199,758 356,082 374,604
Amortization of intangible assets 32,270 34,274 64,845 69,190
Operating income 151,652 164,945 277,629 332,837
Other income (expense):        
Interest income 3,010 1,426 5,212 2,232
Interest expense (32,769) (35,044) (67,770) (69,424)
Other income (expense), net (2,240) (2,663) 3,593 (5,940)
Income before income taxes 119,653 128,664 218,664 259,705
Provision for income taxes 25,392 29,221 49,921 56,308
Net income 94,261 99,443 168,743 203,397
Less: Net income attributable to noncontrolling interests 180 2,423 1,702 3,246
Net income available to Charles River Laboratories International, Inc. 94,081 97,020 167,041 200,151
Calculation of net income per share attributable to common shareholders of Charles River Laboratories International, Inc.        
Net income available to Charles River Laboratories International, Inc. 94,081 97,020 167,041 200,151
Less: Adjustment of redeemable noncontrolling interest 301 0 702 0
Less: Incremental dividends attributable to noncontrolling interest holders 3,792 0 9,022 0
Net income available to Charles River Laboratories International, Inc. common shareholders $ 89,988 $ 97,020 $ 157,317 $ 200,151
Net income attributable to common shareholders:        
Basic (in dollars per share) $ 1.75 $ 1.89 $ 3.06 $ 3.91
Diluted (in dollars per share) $ 1.74 $ 1.89 $ 3.04 $ 3.90
Weighted-average number of common shares outstanding:        
Basic (in shares) 51,551 51,216 51,494 51,157
Diluted (in shares) 51,846 51,467 51,810 51,382
Service        
Total revenue $ 842,900 $ 874,891 $ 1,659,762 $ 1,732,257
Costs and expenses:        
Cost of revenue (excluding amortization of intangible assets) 577,383 578,099 1,155,547 1,143,576
Product        
Total revenue 183,217 185,046 377,915 357,053
Costs and expenses:        
Cost of revenue (excluding amortization of intangible assets) $ 95,021 $ 82,861 $ 183,574 $ 169,103